cerrar
Tagged with IoT

Trad Alkhelaiwi – Country Director, Amgen Saudi Limited
Trad Alkhelaiwi, country director for Amgen in Saudi Arabia, discusses the intricacies of the Saudi healthcare transformation including the push for a…

Hong Kong: HKEX Biotech IPOs in the First Half of 2021
Three years after the Hong Kong Stock Exchange (HKEX) introduced reforms to allow and support the listing of pre-profit biotech companies, it has…

Senthil Sockalingam – Head of IQVIA Biotech, JAPAC &…
IQVIA Biotech JAPAC’s Dr Senthil Sockalingam outlines the evolving needs of the flood of early-stage drug discovery ventures in Asia, how biotechs…

Building a Globally Competitive Innovation Ecosystem in Singapore
Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest some USD 20 billion over the next 5…

HKEX’s Aim to Become World’s #1 Biotech Listing Hub &…
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs to IPO, we look back at a stellar…

Singapore: A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy, government funding towards innovative…

Dun Yang – President & CEO, Anticancer Bioscience
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer…

Michael Bauer – CEO & Board Member, Cellestia
Dr Michael Bauer, a Novartis early development veteran, now serves as CEO of Basel-based Cellestia. Here, Bauer explains why Cellestia’s unique…

Fabian Gerber – Senior Relationship Manager Primary…
Fabian Gerber of SIX Swiss Exchange, Switzerland's principal stock exchange, outlines the importance of life sciences companies to the exchange,…

Josua Jordi – CEO & Co-Founder, EraCal Therapeutics
Josua Jordi of Swiss biotech EraCal explains the company’s technology platform, their work with zebrafish larvae to find a biologic mechanism to…

China Pharma News: BioNTech-Fosun JV; Patent Law Revamp; Hong…
The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up on COVID-19 vaccines; and big…

Piers Ingram – Co-Founder & CEO, Hummingbird…
Dr Piers Ingram, PhD, co-founder, and CEO of Singapore-based biotech Hummingbird Bioscience, shares his motivation for establishing the company in…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here